LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stem Cell Structure to Facilitate In Vitro Embryonic Studies

By LabMedica International staff writers
Posted on 16 Mar 2017
Image: A photomicrograph showing stem cell-modeled mouse embryo at 96 hours (left); Mouse embryo cultured in vitro for 48 hours from the blastocyst stage (right). The red part is embryonic and the blue extra-embryonic (Photo courtesy of Sarah Harrison and Gaelle Recher, Zernicka-Goetz Laboratory, University of Cambridge).
Image: A photomicrograph showing stem cell-modeled mouse embryo at 96 hours (left); Mouse embryo cultured in vitro for 48 hours from the blastocyst stage (right). The red part is embryonic and the blue extra-embryonic (Photo courtesy of Sarah Harrison and Gaelle Recher, Zernicka-Goetz Laboratory, University of Cambridge).
A biological construct that combines mouse embryonic stem cells and extra-embryonic trophoblast stem cells in a three-dimensional scaffold will allow in vitro studies of cellular interaction in a model that mimics a developing embryo.

The development of a mammalian embryo requires intricate interactions between embryonic and extra-embryonic tissues to orchestrate and coordinate cellular differentiation with changes in developmental potential. In order to develop a model system to facilitate the study of embryonic development in vitro, investigators at the University of Cambridge combined genetically modified mouse embryonic stem cells (ESCs) and extra-embryonic trophoblast stem cells (TSCs) with specific inhibitors in a three-dimensional extracellular matrix scaffold.

The objective was to generate a structure that would that would mimic natural early stage embryos in which the ESCs cluster together at one end of the blastocyst. TSCs, which will form the placenta, are also found within the natural blastocyst as are primitive endoderm stem cells that will form the yolk sac.

The investigators reported in the March 2, 2017, online edition of the journal Science they were able to grow a structure capable of self-assembly whose development and architecture very closely resembled the natural embryo. Development of the embryo-like structure depended on molecular crosstalk involving Nodal signaling.

"Both the embryonic and extra-embryonic cells start to talk to each other and become organized into a structure that looks like and behaves like an embryo," said senior author Dr. Magdalena Zernicka-Goetz professor of physiology, development, and neuroscience, at the University of Cambridge. "It has anatomically correct regions that develop in the right place and at the right time."

"We knew that interactions between the different types of stem cell are important for development, but the striking thing that our new work illustrates is that this is a real partnership - these cells truly guide each other," said Dr. Zernicka-Goetz. "Without this partnership, the correct development of shape and form and the timely activity of key biological mechanisms do not take place properly. We think that it will be possible to mimic a lot of the developmental events occurring before 14 days using human embryonic and extra-embryonic stem cells using a similar approach to our technique using mouse stem cells. We are very optimistic that this will allow us to study key events of this critical stage of human development without actually having to work on embryos. Knowing how development normally occurs will allow us to understand why it so often goes wrong."

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more